You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

Cilastatin sodium; imipenem - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for cilastatin sodium; imipenem and what is the scope of patent protection?

Cilastatin sodium; imipenem is the generic ingredient in three branded drugs marketed by Merck, Acs Dobfar, Hospira Inc, Hq Spclt Pharma, and Msd Merck Co, and is included in eight NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Three suppliers are listed for this compound.

Summary for cilastatin sodium; imipenem
US Patents:1
Tradenames:3
Applicants:5
NDAs:8
Finished Product Suppliers / Packagers: 3
Clinical Trials: 2
DailyMed Link:cilastatin sodium; imipenem at DailyMed
Recent Clinical Trials for cilastatin sodium; imipenem

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
M.D. Anderson Cancer CenterPhase 2
Merck Sharp & Dohme Corp.Phase 3

See all cilastatin sodium; imipenem clinical trials

Pharmacology for cilastatin sodium; imipenem

US Patents and Regulatory Information for cilastatin sodium; imipenem

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc IMIPENEM AND CILASTATIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 090825-001 Nov 16, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Msd Merck Co RECARBRIO cilastatin sodium; imipenem; relebactam POWDER;INTRAVENOUS 212819-001 Jul 16, 2019 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Merck PRIMAXIN cilastatin sodium; imipenem POWDER;INTRAMUSCULAR 050630-001 Dec 14, 1990 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira Inc IMIPENEM AND CILASTATIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 091007-001 Nov 16, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Acs Dobfar IMIPENEM AND CILASTATIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 090577-001 Dec 21, 2011 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hq Spclt Pharma IMIPENEM AND CILASTATIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 207594-001 Dec 12, 2019 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for cilastatin sodium; imipenem

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck PRIMAXIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 050587-002 Nov 26, 1985 ⤷  Sign Up ⤷  Sign Up
Merck PRIMAXIN cilastatin sodium; imipenem POWDER;INTRAMUSCULAR 050630-001 Dec 14, 1990 ⤷  Sign Up ⤷  Sign Up
Merck PRIMAXIN cilastatin sodium; imipenem POWDER;INTRAVENOUS 050587-001 Nov 26, 1985 ⤷  Sign Up ⤷  Sign Up
Merck PRIMAXIN cilastatin sodium; imipenem POWDER;INTRAMUSCULAR 050630-002 Dec 14, 1990 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.